April 30 (Reuters) - XOMA Corp XOMA.O :
* XOMA:ADDS ECONOMIC INTERESTS IN 3 FIRST-IN-CATEGORY ASSETS
TO
ROYALTY AND MILESTONE PORTFOLIO INCLUDING XACIATO (CLINDAMYCIN
PHOSPHATE) VAGINAL GEL 2%
* XOMA CORP: PROVIDED $22 MILLION UPFRONT AS NON-DILUTIVE
ROYALTY
CAPITAL SOLUTION TO DARÉ BIOSCIENCE
* XOMA CORP: WILL RECEIVE REMAINING ROYALTIES RELATED TO
XACIATO™
NOT ALREADY INCLUDED IN DARÉ'S DECEMBER 2023 ROYALTY-BACKED
FINANCING AGREEMENT
* XOMA CORP: ENTITLED TO POTENTIAL MILESTONE PAYMENTS BASED
ON
COMMERCIAL SUCCESS OF XACIATO
Source text for Eikon: ID:nGNX83DvdS
Further company coverage: XOMA.O
((Reuters.Briefs@thomsonreuters.com;))